Device China DeviceChina - Home 中文版 zhuce showcase Frequently Asked Questions 主页 English Language 注册参会 路演报名 疑问解答






As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease — faced by families and healthcare systems today. But we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes.


Founded in 1949 as a medical repair company, we're now among the world's largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. Join us in our commitment to take healthcare Further, Together. Learn more at



6 Dimensions Capital is a leading healthcare focused investment firm with an in-depth focus and extensive coverage across China and the United States. The firm’s investment team consists of 24 investment professionals, including 7 Partners and 7 Venture Partners, with offices in Shanghai, San Francisco, Boston and Hong Kong. Collectively, 6 Dimensions Capital currently has AUM of $800 million in 2 USD and 2 RMB-denominated funds, and have cultivated a portfolio of close to 60 companies.


In May 2017, Frontline BioVentures and WuXi Healthcare Ventures, two prominent and complementary China-U.S. healthcare investment firms, merged to form 6 Dimensions Capital. The Shanghai/San Francisco-based Frontline BioVentures has an established healthcare venture investment exposure in China and the Shanghai/Boston-based WuXi Healthcare Ventures has a proven advantage with its access to innovative startups in the U.S.. The merger has created a powerhouse that aims to fund innovation in an optimal position to capture the biggest value appreciation on both sides of the Pacific. 



About OrbiMed

Established in 1989, OrbiMed is the world’s largest healthcare and life sciences-dedicated investment firm. OrbiMed manages approximately USD$15 billion assets and has invested in approximately 300 private companies across a wide range of therapeutic categories and stages of development, over 100 of which have been either listed or acquired. OrbiMed has continued strong performance in public equity as well. OrbiMed Asia, with offices in Shanghai and Mumbai, has established one of the first pan-Asia healthcare-dedicated PE/VC funds.  With over USD$500 million under management, it has made investments in 31 companies. 



Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greater development space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services. Right now Yuansheng has two Renminbi(RMB)funds (Hybrid Fund I and RMB Fund II) under management, with a total size close to two billion RMB, and it has completed 43 investments of high quality projects. By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Nortech Systems

Nortech Systems Incorporated (, based in Maple Grove, Minn., is a full-service EMS provider of wire and cable assemblies, printed circuit board assemblies and higher-level complete box build assemblies for a wide range of industries. Markets served include medical, industrial and aerospace/defense. The company has operations in the U.S., Latin America and Asia. Nortech Systems Incorporated is traded on the NASDAQ Stock Market under the symbol NSYS.


Nortech acquired Devicix in 2015, Devicix is a medical product realization engineering firm.  Devicix is also the engineering and product development services unit for Nortech Systems, Inc. Devicix brings value to medical device OEMs by offering innovative design solutions and comprehensive product development services for Class I, II and III devices for a range of clinical applications with almost successful 50 FDA registered product development cases.


Nortech Systems will provide reliable and most advanced technology in upstream of medical device industry in  China